GlassScriptPhysician profile
Michael F Phillips
NPI 1295743482
$4,503.39
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,446 · 2020: $938 · 2021: $951 · 2022: $1,088 · 2023: $80.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $80.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $80.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,017.79 | 2019-2023 | |
| Pfizer INC. | $528.68 | 2019-2022 | |
| Therapeuticsmd, INC. | $469.53 | 2019-2022 | |
| Exeltis, USA INC. | $356.04 | 2019-2022 | |
| Lupin INC. | $251.61 | 2019-2020 | |
| Asensus Surgical, INC. | $201.09 | 2019 | |
| Avion Pharmaceuticals | $137.64 | 2020-2022 | |
| Allergan, INC. | $135.28 | 2019-2020 | |
| Myovant Sciences INC. | $131.65 | 2022 | |
| Mayne Pharma Commercial LLC | $131.54 | 2022 | |
| Hologic Sales and Service, LLC | $116.76 | 2019 | |
| Vertical Pharmaceuticals, LLC | $95.83 | 2019-2020 | |
| Evofem Biosciences, INC. | $87.47 | 2022 | |
| Novo Nordisk INC | $77.50 | 2020-2022 | |
| Roche Diagnostics Corporation | $70.21 | 2019 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $57.63 | 2021 | |
| Mylan Pharmaceuticals INC. | $49.74 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $47.68 | 2019-2022 | |
| Agile Therapeutics, INC. | $43.86 | 2021-2022 | |
| Amgen INC. | $43.36 | 2019-2020 | |
| Coopersurgical, INC. | $42.94 | 2020-2022 | |
| Organon LLC | $42.38 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $40.22 | 2020-2021 | |
| Millicent US INC | $39.85 | 2020 | |
| Scynexis, INC. | $33.93 | 2022 | |
| Amag Pharmaceuticals, INC. | $25.02 | 2019 | |
| Radius Health, INC. | $24.76 | 2021 | |
| Covidien LP | $24.27 | 2019 | |
| Duchesnay USA Incorporated | $23.39 | 2019 | |
| Davol INC. | $20.98 | 2022 | |
| Astellas Pharma US INC | $19.71 | 2021 | |
| Medicem INC. | $18.99 | 2020 | |
| Kaleo, INC. | $18.54 | 2019 | |
| Relievant Medsystems, INC. | $18.20 | 2022 | |
| Mission Pharmacal Company | $15.10 | 2021 | |
| Lilly USA, LLC | $14.85 | 2022 | |
| Shield Therapeutics INC | $13.85 | 2022 | |
| Minerva Surgical, INC | $11.40 | 2019 | |
| Channel Medsystems, INC. | $4.12 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.